These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16299757)

  • 1. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
    Capp JP
    Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling embryogenesis and cancer: an approach based on an equilibrium between the autostabilization of stochastic gene expression and the interdependence of cells for proliferation.
    Laforge B; Guez D; Martinez M; Kupiec JJ
    Prog Biophys Mol Biol; 2005 Sep; 89(1):93-120. PubMed ID: 15826673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer.
    Stein GS; Montecino M; van Wijnen AJ; Stein JL; Lian JB
    Cancer Res; 2000 Apr; 60(8):2067-76. PubMed ID: 10786661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stochastic phenomena and the tumoral process].
    Capp JP
    Med Sci (Paris); 2014; 30(6-7):693-8. PubMed ID: 25014464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics: surveillance team against cancer.
    Klein G
    Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of stem cells and cancer cells on the basis of gene expression profile stability, plasticity, and robustness: dynamical systems theory of gene expressions under cell-cell interaction explains mutational robustness of differentiated cells and suggests how cancer cells emerge.
    Kaneko K
    Bioessays; 2011 Jun; 33(6):403-13. PubMed ID: 21538414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
    Capp JP
    Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of cancer stem cells.
    Bapat SA
    Semin Cancer Biol; 2007 Jun; 17(3):204-13. PubMed ID: 16787749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.
    Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
    Cancer Res; 2006 Sep; 66(18):9125-33. PubMed ID: 16982755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell hydration as the primary factor in carcinogenesis: A unifying concept.
    McIntyre GI
    Med Hypotheses; 2006; 66(3):518-26. PubMed ID: 16271440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinogenesis, embryogenesis and aging from the view point of the assessment of cell proliferation and differentiation as a stochastic process].
    Golubev AG
    Eksp Onkol; 1984; 6(5):10-5. PubMed ID: 6391907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
    Atkinson SP; Keith WN
    Expert Rev Mol Med; 2007 Mar; 9(7):1-26. PubMed ID: 17352843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.